These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21698077)

  • 1. Optimizing supercritical antisolvent process parameters to minimize the particle size of paracetamol nanoencapsulated in L-polylactide.
    Kalani M; Yunus R; Abdullah N
    Int J Nanomedicine; 2011; 6():1101-5. PubMed ID: 21698077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of supercritical fluid density on nanoencapsulated drug particle size using the supercritical antisolvent method.
    Kalani M; Yunus R
    Int J Nanomedicine; 2012; 7():2165-72. PubMed ID: 22619552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fabrication of composite poly(d,l-lactide)/montmorillonite nanoparticles for controlled delivery of acetaminophen by solvent-displacement method using glass capillary microfluidics.
    Othman R; Vladisavljević GT; Thomas NL; Nagy ZK
    Colloids Surf B Biointerfaces; 2016 May; 141():187-195. PubMed ID: 26852102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery.
    Kalantarian P; Najafabadi AR; Haririan I; Vatanara A; Yamini Y; Darabi M; Gilani K
    Int J Nanomedicine; 2010 Oct; 5():763-70. PubMed ID: 21042422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of supercritical antisolvent method in drug encapsulation: a review.
    Kalani M; Yunus R
    Int J Nanomedicine; 2011; 6():1429-42. PubMed ID: 21796245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supercritical antisolvent production of biodegradable micro- and nanoparticles for controlled delivery of paclitaxel.
    Lee LY; Wang CH; Smith KA
    J Control Release; 2008 Jan; 125(2):96-106. PubMed ID: 18054107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supercritical antisolvent precipitation of PHBV microparticles.
    Costa MS; Duarte AR; Cardoso MM; Duarte CM
    Int J Pharm; 2007 Jan; 328(1):72-7. PubMed ID: 16971075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrospray encapsulation of hydrophilic and hydrophobic drugs in poly(L-lactic acid) nanoparticles.
    Valo H; Peltonen L; Vehviläinen S; Karjalainen M; Kostiainen R; Laaksonen T; Hirvonen J
    Small; 2009 Aug; 5(15):1791-8. PubMed ID: 19360725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ampicillin Nanoparticles Production via Supercritical CO2 Gas Antisolvent Process.
    Esfandiari N; Ghoreishi SM
    AAPS PharmSciTech; 2015 Dec; 16(6):1263-9. PubMed ID: 25771736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microencapsulation of fish oil using supercritical antisolvent process.
    Karim FT; Ghafoor K; Ferdosh S; Al-Juhaimi F; Ali E; Yunus KB; Hamed MH; Islam A; Asif M; Sarker MZI
    J Food Drug Anal; 2017 Jul; 25(3):654-666. PubMed ID: 28911651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design.
    Hao J; Fang X; Zhou Y; Wang J; Guo F; Li F; Peng X
    Int J Nanomedicine; 2011; 6():683-92. PubMed ID: 21556343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The preparation of monodisperse biodegradable polyester nanoparticles with a controlled size.
    Zweers ML; Grijpma DW; Engbers GH; Feijen J
    J Biomed Mater Res B Appl Biomater; 2003 Aug; 66(2):559-66. PubMed ID: 12861608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and physicochemical properties of vinblastine microparticles by supercritical antisolvent process.
    Zhang X; Zhao X; Zu Y; Chen X; Lu Q; Ma Y; Yang L
    Int J Mol Sci; 2012 Oct; 13(10):12598-607. PubMed ID: 23202916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of polycaprolactone nanoparticles via supercritical carbon dioxide extraction of emulsions.
    Ajiboye AL; Trivedi V; Mitchell JC
    Drug Deliv Transl Res; 2018 Dec; 8(6):1790-1796. PubMed ID: 28828703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to control the particle size distribution of poly-epsilon-caprolactone nanoparticles for pharmaceutical applications.
    Lince F; Marchisio DL; Barresi AA
    J Colloid Interface Sci; 2008 Jun; 322(2):505-15. PubMed ID: 18402975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microencapsulation of puerarin nanoparticles by poly(l-lactide) in a supercritical CO(2) process.
    Chen AZ; Li Y; Chau FT; Lau TY; Hu JY; Zhao Z; Mok DK
    Acta Biomater; 2009 Oct; 5(8):2913-9. PubMed ID: 19463980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Part I: Development and optimization of solid-lipid nanoparticles using Box-Behnken statistical design for ocular delivery of gatifloxacin.
    Abul Kalam M; Sultana Y; Ali A; Aqil M; Mishra AK; Aljuffali IA; Alshamsan A
    J Biomed Mater Res A; 2013 Jun; 101(6):1813-27. PubMed ID: 23255511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of bosentan monohydrate/ε-polycaprolactone nanoparticles obtained by electrospraying.
    Giménez VM; Sperandeo N; Faudone S; Noriega S; Manucha W; Kassuha D
    Biotechnol Prog; 2019 Mar; 35(2):e2748. PubMed ID: 30548149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of letrozole-loaded poly(d,l-lactide) nanoparticles for drug delivery in breast cancer therapy.
    Alemrayat B; Elhissi A; Younes HM
    Pharm Dev Technol; 2019 Feb; 24(2):235-242. PubMed ID: 29561210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-circulating polyhydroxybutyrate-co-hydroxyvalerate nanoparticles for tumor targeted docetaxel delivery: Formulation, optimization and in vitro characterization.
    Vardhan H; Mittal P; Adena SK; Mishra B
    Eur J Pharm Sci; 2017 Mar; 99():85-94. PubMed ID: 28002762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.